CLINICAL_TRIALS ClinicalTrials.gov record update

Phase II Study of Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis From Colorectal, Appendiceal, Small Bowel, Gastric, Cholangiocarcinoma, Breast, Ovarian, or Other Gynecologic Primary Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05185947
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:26:46.504148+00:00
Published At: 2025-03-07T00:00:00+00:00
Record Updated At: 2025-03-07
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Gynecologic Cancer", "Gynecologic Neoplasms", "Peritoneal Carcinomatosis", "Peritoneal Neoplasms", "Ovarian Cancer", "Ovarian Neoplasms", "Colorectal Cancer", "Colorectal Neoplasms", "Appendiceal Cancer", "Appendiceal Neoplasms"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-03-07"
protocolSection.identificationModule.nctId: "NCT05185947"
protocolSection.identificationModule.officialTitle: "Phase II Study of Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis From Colorectal, Appendiceal, Small Bowel, Gastric, Cholangiocarcinoma, Breast, Ovarian, or Other Gynecologic Primary Cancer"
protocolSection.statusModule.overallStatus: "ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.